Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2034
May 08, 2024 16:10 ET
|
Phillips Edison & Company, Inc.
CINCINNATI, May 08, 2024 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of grocery-anchored...
SiTime Reports First Quarter 2024 Financial Results
May 08, 2024 16:10 ET
|
SiTime
SANTA CLARA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the Precision Timing company, today announced financial results for the first quarter ended March 31, 2024. ...
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
May 08, 2024 16:10 ET
|
Oculis Holding AG
ZUG, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Clinical programs progressing as planned with initiation of second OCS-01 Phase 3 DIAMOND-2 trial in Diabetic Macular Edema (DME) and completion of...
Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update
May 08, 2024 16:10 ET
|
Pharvaris N.V.
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, currently enrollingEnd-of-Phase 2 meeting scheduled to discuss development plan of deucrictibant...
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024 16:10 ET
|
IGM Biosciences, Inc.
- Enrollment target exceeded in aplitabart randomized colorectal cancer clinical trial - - Enrollment completed in first dose cohort in imvotamab rheumatoid arthritis clinical trial - MOUNTAIN VIEW,...
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)
May 08, 2024 16:10 ET
|
CytomX Therapeutics Inc.
- CX-904 demonstrated a favorable safety profile with no cytokine release syndrome (CRS) of any grade observed in step-dosing cohorts and no grade >1 CRS observed overall - - Encouraging initial...
Crescent Capital BDC, Inc. Reports First Quarter Net Investment Income Per Share of $0.63 and NAV Per Share of $20.28; Increases Quarterly Dividend
May 08, 2024 16:10 ET
|
Crescent Capital BDC
Crescent Capital BDC, Inc. Reports First Quarter Net Investment Income Per Share of $0.63 and NAV Per Share of $20.28; Increases Quarterly Dividend
Profire Energy Reports Financial Results for First Quarter 2024
May 08, 2024 16:10 ET
|
Profire Energy, Inc.
LINDON, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the "Company") that provides solutions which enhance the efficiency, safety, and reliability...
Taboola to Present in Upcoming Investor Conferences
May 08, 2024 16:10 ET
|
Taboola, Inc.
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced that members of its management team will participate...
ContextLogic Inc. Reports First-Quarter 2024 Financial Results
May 08, 2024 16:10 ET
|
ContextLogic Inc.
OAKLAND, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: WISH) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter ended March 31,...